leflunomide has been researched along with acriflavine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dai, R; Guan, D; Guo, B; He, B; He, X; Li, F; Li, J; Liang, C; Liu, J; Lu, A; Lu, C; Wu, X; Xie, D; Zhang, BT; Zhang, G; Zhang, H; Zhang, W; Zhong, C | 1 |
1 other study(ies) available for leflunomide and acriflavine
Article | Year |
---|---|
HIF1α inhibition facilitates Leflunomide-AHR-CRP signaling to attenuate bone erosion in CRP-aberrant rheumatoid arthritis.
Topics: Acriflavine; Adult; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Aryl Hydrocarbon Receptor Nuclear Translocator; Bone Resorption; C-Reactive Protein; Cells, Cultured; Collagen; Female; Hepatocytes; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunosuppressive Agents; Leflunomide; Liver; Male; Mice; Mice, Knockout; Middle Aged; Primary Cell Culture; Rats; Receptors, Aryl Hydrocarbon; RNA, Small Interfering; Signal Transduction; Treatment Outcome | 2019 |